Narula, N. and Hamam, H. 2023. Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases: The Powerful Pill. Canadian IBD Today. 1, S11 (Nov. 2023), 2–11. DOI:https://doi.org/10.58931/cibdt.2023.1S1121.